Connexin 43 (Cx43) is the predominant isoform of gap junction proteins in the working myocardium. In the heart, mitogenactivated protein (MAP) kinases are implicated in regulating Cx43 remodeling; however, their precise roles remain obscure. Mitogen-activated protein kinase kinase 4 (MKK4) is a critical component of the stressactivated MAP kinase signaling pathway. We have previously demonstrated that MKK4 antagonizes cardiomyocyte hypertrophy. Herein, we investigate the role of MKK4 in regulating Cx43 expression in cardiomyocytes. We found that knockdown of MKK4 expression or inhibition of its kinase activity in neonatal rat cardiomyocytes (NRCMs) significantly reduced phenylephrine-induced Cx43 expression. Furthermore, two activator protein-1 (AP-1) binding elements in the Cx43 promoter region were identified as being responsible for the MKK4-regulated Cx43 expression. Consistently, we also detected heterogeneously reduced Cx43 expression and attenuated zonula occludens-1 (ZO-1) content in the hearts of MKK4 cardiomyocyte-specific knockout mice (MKK4 cko ) following pressure overload. To test whether heterogeneously reduced Cx43 expression contributes to ventricular arrhythmic vulnerability, MKK4 cko and control mice were subjected to pressure overload followed by programmed electrical stimulation (PES). 6 of 13 MKK4 cko mice, but none of the controls, developed ventricular tachycardia. Epicardial activation mapping recorded from the MKK4 cko hypertrophied heart showed ventricular activation delay. Mathematical models have simulated that the spatially heterogeneous decrease in Cx43 http://www.jbc.org/cgi
Connexin 43 (Cx43) is the predominant isoform of gap junction proteins in the working myocardium. In the heart, mitogenactivated protein (MAP) kinases are implicated in regulating Cx43 remodeling; however, their precise roles remain obscure. Mitogen-activated protein kinase kinase 4 (MKK4) is a critical component of the stressactivated MAP kinase signaling pathway. We have previously demonstrated that MKK4 antagonizes cardiomyocyte hypertrophy. Herein, we investigate the role of MKK4 in regulating Cx43 expression in cardiomyocytes. We found that knockdown of MKK4 expression or inhibition of its kinase activity in neonatal rat cardiomyocytes (NRCMs) significantly reduced phenylephrine-induced Cx43 expression. Furthermore, two activator protein-1 (AP-1) binding elements in the Cx43 promoter region were identified as being responsible for the MKK4-regulated Cx43 expression. Consistently, we also detected heterogeneously reduced Cx43 expression and attenuated zonula occludens-1 (ZO-1) content in the hearts of MKK4 cardiomyocyte-specific knockout mice (MKK4 cko ) following pressure overload. To test whether heterogeneously reduced Cx43 expression contributes to ventricular arrhythmic vulnerability, MKK4 cko and control mice were subjected to pressure overload followed by programmed electrical stimulation (PES). 6 of 13 MKK4 cko mice, but none of the controls, developed ventricular tachycardia. Epicardial activation mapping recorded from the MKK4 cko hypertrophied heart showed ventricular activation delay. Mathematical models have simulated that the spatially heterogeneous decrease in Cx43 causes slowed ventricular conduction and fragmented wave propagations leading to reentrant excitations. Collectively, these data reveal a novel role for MKK4 in regulating Cx43 expression and preventing hypertrophyassociated arrhythmogenesis.
Cx43 is the predominant isoform of gap junction proteins in the working myocardium. It forms low-resistance cell-to-cell channels allowing ions and small molecules to move between adjacent cells and facilitating the orderly spread of the excitation wave responsible for synchronous contraction of the heart (1) . Alterations in Cx43 expression may contribute directly to the arrhythmic substrate, as evidenced by studies in mice with a cardiomyocyte-specific deletion of Cx43. Loss of Cx43 expression in the heart results in sudden arrhythmic death due to increased gap junctional resistance and slowed conduction velocity, which form a substrate for re-entrant arrhythmias (2) (3) (4) . Cx43 has a fast turnover rate with a half-life in the range of 1-5 hour, implying a highly regulated process for its synthesis, trafficking and degradation (1, 5) . In the heart, mitogen-activated protein (MAP) kinases are implicated in regulating Cx43 remodeling by either phosphorylation-or transcription-dependent mechanisms (6) (7) (8) (9) (10) (11) ; however, their precise roles are ambiguous. For example, activation of JNK in cardiomyocytes was correlated with the upregulation of Cx43 after amphetamine treatment (6) , whereas, Petrich et al reported that in the hearts of transgenic mice overexpressing constitutive active MKK7 increased JNK activity was accompanied by a substantial reduction in Cx43 expression (7, 8) . MKK4 is a critical component of the stressactivated MAP kinase signaling pathway which activates JNKs to regulate diverse physiological processes (12) . It was observed in vitro that MKK7 and MKK4 preferentially phosphorylate JNK on threonine 183 and tyrosine 185, respectively (13, 14) . The targeted deletion of the mkk4 or mkk7 gene leads to embryonic lethality, providing genetic evidence that MKK4 and MKK7 have nonredundant roles in vivo (12) . This concept is underscored by the observation in mice with brain-specific ablation of mkk4 that decreased JNK activity caused a defect in neuronal migration and premature death (15) . Furthermore, we have provided substantial evidence demonstrating the functional importance of MKK4 in the heart where it is required in protecting the heart from maladaptive pathological hypertrophy (16) . In the current study we investigated the role of MKK4 in regulating Cx43 expression in cardiomyocytes in response to hypertrophic stress. We found in NRCMs that knockdown of endogenous MKK4 expression by siMKK4 or inhibition of its kinase activity by infection of an adenovirus encoding a dominantnegative form of MKK4 (Ad-dnMKK4) caused a substantial reduction in Cx43 expression together with inactivation of JNK/c-Jun pathway after phenylephrine (PE) stimulation. To gain insight into the mechanism responsible for the decreased Cx43 transcript level, luciferase reporter assays were performed in siMKK4-or Ad-dnMKK4-NRCMs in which blunted Cx43-promoter reporter activity was detected after PE treatment. We have also demonstrated that MKK4 regulates Cx43 transcription most likely by virtue of two AP-1 binding sites in the Cx43 proximal promoter region. Consistent with these data, we observed decreased transcript and protein levels of Cx43 in the MKK4-deficient myocardium after one week of transverse aortic constriction (TAC). Furthermore, the remaining Cx43 was found to be heterogeneously distributed in the MKK4 cko -TAC hearts. In addition, we discovered a reduction in ZO-1 protein expression in the MKK4 
EXPERIMENTAL PROCEDURES

Animal models
MKK4
f/f and their littermates MKK4 cko mice were previously generated (16) and used in the present study. All mice were maintained in a pathogen-free facility at the University of Manchester. The animal studies were performed in accordance with the UK Home Office and institutional guidelines. Quantitative real-time PCR Total RNA was prepared from NRCMs or ventricular tissues. Real-time quantitative PCRs were performed using the SYBR-green I Core Kit (Eurogentec). The primers used for detection of Cx43 and GAPDH expression were obtained from Qiagen.
Immunoblot analysis
Protein extracts (50 µg) were subjected to immunoblot analysis with antibodies against Cx43, N-cadherin, β-catenin, plakoglobin, tubulin (Sigma); ZO-1 (Zymed); MKK7, JNK, c-Jun, phospho-JNK and phosho-cJun (Cell Signalling); MKK4 (BD Pharmingen).
Immunohistochemical analyses
Fresh cryosections of ventricular tissues were used to analyze Cx43, N-cadherin, β-catenin and plakoglobin by indirect immunofluorescence. As secondary antibodies, goat anti-mouse or goat anti-rabbit antibodies, conjugated to Alexa Fluoro 488 (Invitrogen), or Alexa Fluoro 568 (Invitrogen), respectively, were used.
Adenovirus vector construction
Using the vector containing the rat Cx43 (rCx43) promoter region (-148, +280) as a template, we created a single mutations at either the AP-1 (-47, -39) site, or the AP-1 (-122, -112) site, or double mutations at both AP-1 sites using the QuikChange site-directed mutagenesis kit (Stratagene). Adenovirus expressing wild type Cx43 promoter-Luc or various mutations was generated using ViraPower Adenoviral Expression System (Invitrogen). Luciferase reporter assay 48h post-transfection of siRNA, NRCMs were infected with Ad--Cx43APwt-Luc for 24h.
Following PE treatment (100 μM, 24h), aliquots of NRCM lysates were assayed for luciferase activity using a luciferase assay kit (Promega). To measure rCx43 promoterluciferase activity after blocking MKK4 activation, NRCMs were infected with AddnMKK4 for 24h prior to the infection of AdCx43APwt-Luc for a further 24h. Then, NRCMs were treated with 100 μM PE for 24h followed by the luciferase assay. To determine whether MKK4-regulated Cx43 transcription was dependent on AP-1 transcriptional activity, NRCMs were first infected with either Ad-GFP or Ad-caMKK4 for 24h, Ad-Cx43APwt-Luc, or Ad-Cx43APma-Luc, or AdCx43APmb-Luc, or Ad-Cx43APdm-Luc was added to either Ad-GPF-NRCMs or AdcaMKK4-NRCMs for a further 24h. Luciferase activity in each experimental group was then measured described as above. Electrocardiography (ECG) 8-10 week old male MKK4 f/f and MKK4 cko mice were subjected to either sham or TAC operation for one week as previously described (16) . To monitor cardiac rhythms at baseline and in hypertrophic condition we carried out in vivo ECG analysis on anesthetized mice. RR interval, P wave duration, PR interval, QRS, JT and QT durations were recorded.
Programmed electrical stimulation (PES)
To assess propensity to ventricular arrhythmias, one week TAC-treated mice were subjected to PES. A pacing train of eight stimuli (S1) was delivered at a basic cycle length of 100 ms, with a single (S2) premature extrastimulus introduced at progressively shorter intervals until an arrhythmia was induced or the ventricular refractory period was reached.
Epicardial activation mapping
Epicardial activation mapping of left ventricular free wall (LVFW) was recorded in isolated Langendorff-perfused hearts using a custom-made 64 separated electrodes (8 x 8 grids, 0.55 mm spacing) at a basic cycle-length of 100 ms. The activation time was determined as the point of maximal negative slope and displayed in a grid representing the layout of the original recording array. All activation times were related to the timing of the first detected waveform. Isochrones were drawn manually around areas activated in steps of 1 ms.
Statistical analysis
Data are expressed as mean ± SEM and analyzed using two-way ANOVA followed by Bonferonni's post-test where appropriate.
Comparisons between two groups were performed using Student's t-test. P-values <0.05 are considered statistically significant. An expanded methods section is available online.
RESULTS
MKK4 regulates Cx43 gene expression via AP-1 binding sites
Transcriptional regulation is a key mechanism dictating Cx43 expression. The downregulation of Cx43 ascribable to altered transcriptional regulation has been reported in many forms of heart disease (17, 18) . To investigate whether MKK4 regulates Cx43 expression in response to hypertrophic stress, we first examined Cx43 mRNA level and protein expression in NRCMs in which endogenous MKK4 protein was knocked down by 70% using siMKK4 ( Figure 1A ). Blunted phosphorylation of JNK and c-Jun after PE stimulation was observed when MKK4 expression was deficient ( Figure 1A ). In response to PE stimulation (100 μM, 48h), siMKK4-NRCMs showed a significant reduction in Cx43 mRNA level, and a corresponding substantial decrease in its protein expression was also detected ( Figure  1B ). We performed a systematic promoterreporter study in NRCMs to determine the regulation of rat Cx43 (rCx43) proximal promoter by MKK4. NRCMs were pre-treated with siMKK4 prior to infection with a recombinant adenovirus encoding the rCx43 promoter region (-148, +281, containing two AP-1 binding sites, Ad-Cx43APwt-Luc). Following PE stimulation (100 μM, 24h), a significant decline in rCx43 promoterluciferase activity was detected in siMKK4-NRCMs versus that in the control siRNANRCMs ( Figure 1C ). To corroborate these data, we then infected NRCMs with a recombinant adenovirus expressing a dominant-negative form of MKK4 (AddnMKK4) to block activation of the JNK/cJun pathway ( Figure 1D ). Similarly, significantly reduced Cx43 mRNA and protein levels were observed in Ad-dnMKK4-NRCMs ( Figure 1E ). Moreover, PE stimulation failed to induce a similar extent of rCx43 promoterluciferase activity in Ad-dnMKK4-NRCMs, compared to that in Ad-GFP-NRCMs ( Figure  1F ). To determine whether MKK4-regulated Cx43 transcription is dependent on AP-1 transcriptional activity, we generated various recombinant adenoviruses containing either a single mutation at the AP-1 (-47, -39) site, referred to as Ad-Cx43APma-Luc; or mutation at the AP-1 (-122, -112) site, referred to as AdCx43APmb-Luc, or double mutations at both AP-1 binding sites (Ad-Cx43APdm-Luc) ( Figure 2A ). As shown in Figure 2B , infection of adenovirus encoding constitutively active MKK4 (Ad-caMKK4) significantly increased the Ad-Cx43APwt-Luc activity in NRCMs. Conversely, Ad-Cx43APdm-Luc activity proved to be considerably decreased even at basal level, co-infection of Ad-caMKK4 into NRCMs failed to restore its luciferase activity. Co-infection of Ad-caMKK4 with either AdCx43APma-Luc or Ad-Cx43APmb-Luc could not render a similar level of luciferase activity as Ad-Cx43APwt-Luc. Together, these results indicate that MKK4 is required for Cx43 transcription, acting through two AP-1 binding sites in the Cx43 proximal promoter via JNK/c-Jun activation. Decreased Cx43 protein expression is likely attributable to reduced its mRNA level.
Heterogeneous reduction of Cx43 in MKK4
cko -TAC mice Prompted by the above findings, we then analyzed Cx43 mRNA level, protein content and distribution in the MKK4-deficient myocardium. As shown in Figure 3A , a downregulation of Cx43 transcript was detected in the MKK4 cko hearts one week after transverse aortic constriction (TAC) was applied to induce a pressure overload and subsequent hypertrophy on the heart. Accordingly, we observed a decreased Cx43 protein level (around 50% of controls) in the MKK4 cko heart following one week TAC ( Figure 3B ), and heterogeneity in Cx43 distribution shown by the absence of Cx43 labeling in some patches of the MKK4 cko ventricular free wall; while in some patches of myocardium, Cx43 labeling was scattered in the cytoplasm ( Figure 3C) Figure 4A ), this result was further confirmed by immunohistochemistry ( Figure  4B ). In addition, we analyzed N-cadherin, β-catenin and plakoglobin expression, all of which are important for the assembly and maintenance of Cx43 at the plasma membrane (1, 21) . Expression and localization of these junctional proteins were not visibly different between the controls and MKK4 cko -TAC mice as shown by immunoblotting and immunohistochemistry (Supplemental Figure  I) . Examination of the structure of MKK4-decificent cardiomyocytes by transmission electron microscopy (TEM) surprisingly showed that the structure of myofibrils, sarcomeres and Z-lines appeared normal in the MKK4 cko -TAC cardiomyocytes relative to the controls (Supplemental Figure II) . Adherens junctions and demosomes characterized as submembranous electron dense zones in the vicinity of intercellular spaces were visible in both genotypes (Supplemental Figure II) (Table 1) . QRS/QTc ratio was also significantly greater in the MKK4 cko -TAC heart compared to that in the control heart. However, no significant differences in JT intervals were observed in the two TAC groups (Table 1) . These ECG parameters indicate slowed ventricular conduction in the MKK4 cko -TAC heart. Next, we performed PES to evaluate whether the heterogeneous decrease in Cx43 and slowed ventricular conduction sensitised MKK4 cko mice to ventricular arrhythmias. A train of 8 stimuli (S1) was delivered at a basic cycle length of 100 ms, with a single extrastimulus (S2) added at progressively shorter intervals to induce ventricular arrhythmias. This S1-S2 pacing protocol induced multiple (>6) episodes of VT in 6 of 13 MKK4 cko -TAC mice, which lasted 1333±182 ms ( Figure 5A ). Ventricular effective refractory period (VERP) was also determined by the same S1-S2 protocol. Consistent with the wider QRS duration, we noted a prolonged VERP in the MKK4 cko -TAC heart ( Figure 5B ). To examine whether heterogeneously reduced Cx43 expression in MKK4-decifient myocardium affects ventricular electrical propagation, epicardial mapping of electrical activity of the left ventricular free wall (LVFW) was performed on the isolated Langendorff-perfused hearts. As illustrated in Figure 5C , ventricular activation was significantly delayed in the MKK4 cko -TAC heart, as shown by slowed conduction velocity (CV) at both longitudinal and transverse directions in the MKK4 cko -TAC heart, compared with that in the control heart ( Figure 5D ). Computational simulations of Cx43 remodeling To substantiate the data from epicardial activation mapping, computer simulations were performed to address whether or not patched Cx43 reduction is pro-arrhythmic as suggested in this and previous studies (3, (21) (22) (23) . First, we implemented a mathematical model of mouse ventricular myocytes to study CV in homogeneous tissue consisting of 100 cells. In this model the changes in CV and wavelengths were studied based on an equivalent percentage of intercellular electrical coupling reduction uniformally across the strand to the reduced level of Cx43 expression observed in the MKK4 cko -TAC heart. As expected, the control CV of solitary wave in strands of mycoytes was 0.603 mm/ms at an S1-S2 interval of 100 ms, however, a diminution in intercellular electrical coupling by 50% reduced the solitary wave CV to 0.415 mm/ms. Accordingly, the control wavelength (wavelength = CV × averaged APD 90 across the strand) of the solitary wave was 11.6 mm, and when intercellular electrical coupling was reduced by 50%, the wavelength was reduced to 8.8 mm, which is attributable to the decreased CV ( Figure 6A-C) . Further simulations were performed in a 2D model of homogeneous ventricular tissue (the ventricular tissue has a size of 10 mm x 10 mm with 200 x 200 cells) to study the effects of an arbitrarily and randomly distributed pattern of patched reduction in the intercellular electrical coupling on CV of planer and circular waves. With patched reduction of gap junctional coupling, break-up of the wavefronts was observed in all cases ( Figure  6D ). These patches gave distorted wavefronts of the planer and circular waves, leading to fragmented wavefronts forming multiple reentrant excitation wavelets. Together, the simulations show that heterogeneously reduced intercellular electrical coupling due to heterogeneously reduced expression of Cx43 most likely contributes to slowed conduction velocity, fragmented wavefronts of excitation waves, which increased propensity for arrhythmias. 
DISCUSSION
Regulation of Cx43 expression by MKK4
Assembly of gap junctions is a multiphase process, including connexin synthesis, trafficking, and formation of intercellular channels, of which connexin synthesis is the rudimentary step. It has been shown that the Cx43 promoter region contains several putative transcription factor binding sites for AP-1, cAMP response element, and specific protein-1 (SP-1), all of which are thought to be involved in up-regulation of Cx43 transcription (24, 25) . On the other hand, muscle segment homeobox genes Msx1/2 can function in concert with T-box factors Tbx2/3 to repress Cx43 expression (26) . Despite this progress in understanding transcriptional regulation of Cx43, the genetic control mechanisms underlying the spatial and temporal expression pattern of Cx43 remain exclusive. In the current study, we have provided several lines of evidence to demonstrate MKK4 regulation of Cx43 gene expression: 1) knockdown of endogenous MKK4 expression by siMKK4 or inhibition of its kinase activity by infection of Ad-dnMKK4 caused a substantial reduction in Cx43 expression; 2) luciferase reporter assays showed blunted Cx43-promoter reporter activity in siMKK4-or Ad-dnMKK4-NRCMs after PE treatment; 3) increased MKK4 activation in NRCMs resulted in elevated Cx43-promoter reporter activity; 4) luciferase assays using mutations in the Cx43 promoter region demonstrated that MKK4-regulated Cx43 transcription is dependent on AP-1 transcriptional activity. Consistent with these data, decreased Cx43 expression was also detected in the MKK4 cko -TAC heart. Of note, there was a similar reduction of Cx43 at both the mRNA and protein level. We thus believe that the MKK4/JNK/c-Jun pathway regulates Cx43 transcription via AP-1 activity in cardiomyocytes under hypertrophic stress and that decreased Cx43 protein expression is likely attributable to its reduced mRNA level.
Cx43 is a highly phosphorylated and regulated protein. It has been proposed that phosphorylation of Cx43 is related to its internalization (5); however, previous studies have also demonstrated that dephosphorylated Cx43 is associated with trafficking/endocytosis in the cytoplasm, while those gap junctions remaining in the intercalated disc contain phosphorylated Cx43 (27, 28) . In our experimental setting, we presently can not rule out that (de) phosphorylation of Cx43 contributes to its reduction and heterogeneous expression in MKK4 cko -TAC cardiomyocytes. However, the migratory pattern of Cx43 on SDS-PAGE gel electrophoresis appeared similar in both controls and MKK4 cko -TAC hearts. Alterations in Cx43 phosphorylation status may not always be reflected in its mobility on polyacrylamide gels and, therefore, additional studies employing antibodies specific for different phosphorylated isoforms of Cx43 are necessary to resolve this issue.
The roles of junctional proteins in MKK4
cko -TAC mice It has become apparent that molecular "cross talk" exists between gap junctions and adherens junctions or desmosomes. For example, cardiac-specific perturbation of Ncadherin leads to the formation of an arrhythmogenic substrate by an alteration in Cx43 (29, 30) . β-catenin, in addition to scaffolding N-cadherin to actin, also contributes to transcriptional regulation of Cx43 (31) . Mutations in plakoglobin are linked to a rare recessive disorder, Naxos disease (32) . Interestingly, Cx43 levels are remarkably decreased in the hearts of Naxos disease patients, who present with right ventricular cardiomyopathy accompanied by a high incidence of arrhythmias and sudden cardiac death (32) . ZO-1, in fact, physically associates with Cx43 acting as an adaptor, which anchors gap junctions to the cytoskeleton (20, 33) . Abolition of the association of ZO-1 and Cx43 results in a reduction in the number of gap junction plaques and an increase in mean plaque size (33) . In the present study, we did not observe visible abnormalities in the expression and distribution of N-cadherin, β-catenin and plakoglobin in the MKK4 cko heart. However, ZO-1 expression proved to be significantly decreased in the MKK4 cko hypertrophic heart. This reduction of ZO-1 expression may underlie the observed diffused expression of Cx43, part of which was detected in the cytoplasm. It is presently unclear whether MKK4 deficiency is directly responsible for the decreased ZO-1 expression, or whether it is secondary to the reduction of Cx43 expression.
Loss of MKK4 couples hypertrophic signals to arrhythmogenesis
Cell to cell coupling and myocardial tissue architecture are thought to be major factors dictating normal impulse propagation through the heart (34). QRS duration is determined by impulse conduction velocity and cardiomyocyte size (35) . One week after TAC, MKK4 cko mice displayed increased cardiac hypertrophy as indicated by enlarged crosssectional area (346.5±3.26 μm 2 ) compared with 252.4±6.88 μm 2 cross-sectional area in the MKK4 f/f cardiomyocyte (16) . In the present study, ECG recordings showed prolonged QRS duration and greater QRS/QTc ratio in the MKK4 cko -TAC heart, whereas JT intervals did not appear significantly different between the two TAC groups. Epicardial activation mapping demonstrated delayed ventricular electrical propagation in the MKK4 cko -TAC heart. Together, these results indicate that the MKK4 cko -TAC heart had slowed ventricular conduction, which is likely attributed to patchy Cx43 reduction together with increased cardiomyocyte size. Furthermore, in the hypertrophied MKK4 cko heart, heterogeneity in Cx43 expression is thought to result in cardiomyocyte uncoupling, which creates the non-uniformities required for initiating breaks in a propagating wave front. The mathematical models in this study have simulated this phenomenon. Computational simulations demonstrate that this spatially heterogeneous decrease in Cx43 accounts for slowed ventricular conduction and fragmented wave propagations, a critical factor for arrhythmogenesis. Previous studies have shown that ventricular myocardium is not homogeneous; it has electrophysiologically distinct cell types, which give rise to transmural voltage gradients and a dispersion of repolarization (36) . Heterogeneity in Cx43 distribution has been correlated with increased transmural dispersion in refractoriness (37) , and the hypertrophic response of enlarged myocardium mass, is believed to add additional factors to transmural dispersion of repolarization, augmenting electrical heterogeneities intrinsic to the ventricular myocardium. As such, it is plausible that heterogeneously reduced Cx43 expression together with increased hypertrophy predispose MKK4 cko mice to ventricular arrhythmias. We have noticed that although a significant decrease in Cx43 expression at both the mRNA and protein level in all MKK4 cko -TAC hearts, however 6 of 13 mutant mice developed ventricular tachycardia when in vivo ventricular programmed pacing was introduced. The possible reasons for such individual discrepancy in occurrence of ventricular tachycardia could be due to the heterogeneous reduction and distribution of Cx43 in MKK4 cko -TAC mice, or due to individual difference in the extent of hypertrophy induced by TAC hence leads to a non-uniform reduction and/or distribution of Cx43 in MKK4 cko -TAC mice, or due to the nature of the different response (changes in Cx43 expression) of individual mouse to TAC stress and genetic modification of MKK4. Noteworthy, apart from cardiomyocytes, interstitial collagen deposition is also responsible for cardiac tissue architecture.
Increased interstitial fibrosis, especially reparative fibrosis, which replaces zones of dead cardiomyocytes with collagen within muscle bundles, can disrupt impulse propagation. This type of fibrotic change is expected to amplify the effect of conduction slowing and electrical uncoupling in the areas of Cx43 remodeling. Interestingly, one week of TAC treatment did not cause apparent apoptosis and fibrosis in MKK4 cko mice (16), thus involvement by interstitial fibrosis in ventricular tachycardia occurrence in MKK4 cko mice can be excluded.
Conclusion
In summary, we have identified a new role for MKK4 in regulating Cx43 expression in cardiomyocytes. MKK4 is a critical regulator in the heart for maintaining Cx43 expression/distribution, which are important for preservation of normal cardiac electrical function. The recognition of the functional significance of MKK4 in preventing arrhythmogenesis, together with our previous findings that MKK4 antagonizes pathological hypertrophy, may lead to the development of better therapies for treating hypertrophyassociated ventricular arrhythmias. 
